Ommati Mohammad Mehdi, Farshad Omid, Ghanbarinejad Vahid, Mohammadi Hamid Reza, Khadijeh Mousavi, Negar Azarpira, Zahra Mahboubi, Ilkhaninasab Farshid, Moezi Leila, Heidari Reza
College of Life Sciences, Shanxi Agricultural University, Taigu, P. R. China.
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Drug Res (Stuttg). 2020 Jan;70(1):49-56. doi: 10.1055/a-1017-5085. Epub 2019 Oct 31.
Ifosfamide (IFO) is an alkylating agent administered against different types of malignancies. Several cases of renal injury and serum electrolytes disturbances have been reported in IFO-treated patients. Oxidative stress and mitochondrial dysfunction are suspected of being involved in the mechanism of IFO nephrotoxicity. Carnosine is a dipeptide which its antioxidant and mitochondria protecting properties have been mentioned in different experimental models. The current study aimed to evaluate the nephroprotective properties of carnosine against IFO-induced renal injury.
Rats were treated with IFO (50 mg/kg, i.p) alone or in combination with carnosine. Serum and urine biomarkers of renal injury in addition to kidney markers of oxidative stress were evaluated. Moreover, kidney mitochondria were isolated, and some mitochondrial indices were assessed.
Elevated serum creatinine and BUN, hypokalemia, and hypophosphatemia, in addition, to an increase in urine glucose, protein, γ-GT, and alkaline phosphatase (ALP), were evident in IFO-treated animals. IFO also caused an increase in kidney reactive oxygen species (ROS) and lipid peroxidation (LPO). Renal GSH levels and antioxidant capacity were also depleted with IFO therapy. Mitochondrial dehydrogenase activity, GSH level, membrane potential, and ATP content were decreased while mitochondrial LPO and permeabilization were increased in IFO group. Carnosine (250 and 500 mg/kg, i.p) mitigated IFO-induced oxidative stress and mitochondrial impairment in renal tissue.
Our data suggest mitochondrial dysfunction and oxidative stress as fundamental mechanisms of renal injury induced by IFO. On the other hand, carnosine supplementation protected kidneys against IFO-induced injury through regulating mitochondrial function and mitigating oxidative stress.
异环磷酰胺(IFO)是一种用于治疗不同类型恶性肿瘤的烷化剂。已有多例接受IFO治疗的患者出现肾损伤和血清电解质紊乱的报道。氧化应激和线粒体功能障碍被怀疑参与了IFO肾毒性的机制。肌肽是一种二肽,其抗氧化和线粒体保护特性在不同的实验模型中已有提及。本研究旨在评估肌肽对IFO诱导的肾损伤的肾保护特性。
大鼠单独接受IFO(50mg/kg,腹腔注射)或与肌肽联合治疗。评估了肾损伤的血清和尿液生物标志物以及氧化应激的肾脏标志物。此外,分离了肾脏线粒体,并评估了一些线粒体指标。
在接受IFO治疗的动物中,血清肌酐和尿素氮升高、低钾血症和低磷血症,此外,尿葡萄糖、蛋白质、γ-谷氨酰转移酶(γ-GT)和碱性磷酸酶(ALP)增加均很明显。IFO还导致肾脏活性氧(ROS)和脂质过氧化(LPO)增加。IFO治疗还使肾脏谷胱甘肽(GSH)水平和抗氧化能力降低。在IFO组中,线粒体脱氢酶活性、GSH水平、膜电位和ATP含量降低,而线粒体LPO和通透性增加。肌肽(250和500mg/kg,腹腔注射)减轻了IFO诱导的肾组织氧化应激和线粒体损伤。
我们的数据表明线粒体功能障碍和氧化应激是IFO诱导肾损伤的基本机制。另一方面,补充肌肽通过调节线粒体功能和减轻氧化应激保护肾脏免受IFO诱导的损伤。